谷歌Chrome浏览器插件
订阅小程序
在清言上使用

A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma

Qijia Tan, Jiamin Lu, Jingtong Liang, Yuchen Zhou, Chunrong Yang, Zhiqiang Zhang, Cong Li

International review of neurobiology(2023)

引用 0|浏览4
暂无评分
摘要
Glioma is the most common primary central nervous tumor and its malignant and high recurrence rate are seriously threatening patient's life. The prognosis of glioma patients is still poor with a variety of modern treatments. Traditional Chinese medicine (TCM) is widely used in the adjuvant treatment or alternative medicine of glioma. Curcumae Rhizoma is one of the most commonly used in traditional Chinese medicine prescriptions for its anti-tumor characteristics. There are also many studies that reveals the anti-tumor effect of its active ingredients and some of which have been made into drugs and have been used in clinical practice. This review summarizes the new research progress on Curcumae Rhizoma for the treatment of glioma in recent years.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要